Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
BetterLife Pharma Inc. (BETRF) had Non-Operating Income/Expense of $-0.59M for the most recently reported fiscal quarter, ending 2026-07-31.
| Income Statement Financials | |
-- |
|
$-1.49M |
|
-- |
|
-- |
|
$0.91M |
|
$-0.91M |
|
|
Non-Operating Income/Expense |
$-0.59M |
$-1.50M |
|
$-1.50M |
|
$-1.50M |
|
$-1.50M |
|
$-1.50M |
|
$-1.50M |
|
$-0.91M |
|
$-0.91M |
|
162.32M |
|
162.32M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$1.47M |
|
-- |
|
-- |
|
$1.47M |
|
$6.93M |
|
$0.02M |
|
$0.02M |
|
$6.95M |
|
$-5.48M |
|
$-5.48M |
|
$-5.48M |
|
165.55M |
|
| Cash Flow Statement Financials | |
$-1.18M |
|
-- |
|
$1.87M |
|
$0.01M |
|
$0.70M |
|
$0.69M |
|
$0.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.21 |
|
-- |
|
-- |
|
-0.00 |
|
-0.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.18M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
27.31% |
|
27.31% |
|
-102.20% |
|
27.41% |
|
$-0.03 |
|
$-0.01 |
|
$-0.01 |
|